Navigation Links
A Media Event on Clinical Developments in Gene and Cell Therapy
Date:5/9/2013

Salt Lake City, UT (PRWEB) May 09, 2013

Academic and industry leaders in gene and cell therapy will be featured at an American Society of Gene & Cell Therapy (ASGCT) Media Event in Salt Lake City, Utah, on Thursday, May 16th, from 9:40 am – 10:20 am, followed immediately by a one-on-one interview session with ASGCT scientists at 10:20 am – 11:45 am. The American Society of Gene and Cell Therapy boasts of a membership consisting of experts bringing clinical breakthroughs to a wide array of diseases and disorders. These advances are positioned to bring meaningful therapies to children and adults, including those suffering from both inherited and acquired illnesses.

The event will profile exciting clinical results reported in patients suffering from serious and often deadly diseases such as liver cancer, ovarian cancer, lymphoma, hemophilia, and many more. For further details, please consider the following examples:

ASGCT scientists will report dramatic results in children and adult patients with Leukemia using gene-modified immune cells that kill tumors specifically while sparing normal tissues in patients. After injected into the blood stream, these cells performed a seek-and-destroy mission of the cancer cells in patients that led to complete remission of their diseases.

Late stage clinical development of live viruses that reproduce only in cancer cells but not normal tissues which, after injection into cancer patients, acted like laser-guided smart bombs that destroyed the tumors without major side effects.

Groundbreaking work will be reported for the orphan disease Aromatic L-Amino Acid Decarboxylase (AADC). This is a progressive fatal disorder whereby children lose all of their motor abilities and die by the age of six years as their parents helplessly stand by. Children who could not sit or control their head movement were treated with gene therapy and have demonstrated remarkable improvement.

Hemophilia researchers have successfully treated men living with this bleeding disorder with gene therapy. These patients, who had spent their entire lives being injected with life-saving clotting factors, have discontinued protein replacement altogether. Investigators have also treated children born with devastating genetic illnesses such as Pompe Disease.

The press event will take place in Room 150ABC in the Salt Palace Convention Center.

Members of the media will also receive complimentary full-access registration to the ASGCT 16th Annual Meeting at the Salt Palace Convention Center. Media representatives who wish to attend may contact ASGCT directly at 414.278.1341 or info(at)asgct(dot)org.

The American Society of Gene & Cell Therapy (ASGCT) is a professional nonprofit medical and scientific organization dedicated to the understanding, development and application of genetic and cellular therapies and the promotion of professional and public education in the field. For more information on ASGCT, visit its website, http://www.asgct.org.

###

Read the full story at http://www.prweb.com/releases/2013/5/prweb10719123.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cell Culture Market (Media, Sera, Reagents, Serum-Free Media, Albumin, Growth Factors & Cytokines, Instruments, Bioreactors, Roller Bottle Equipment, T-Flasks And Cryostorage Equipment) - Global Industry Analysis, Size, Share, Growth, Trends And For
2. Cell Culture: The Market for Media, Sera and Reagents, 5th Edition
3. Verdad Media is Now Offering eCommerce SEO Services
4. CPAP Shop Launches Social Media Contest to Promote Sleep Apnea Awareness
5. Mold Plagues New Florida Home Owners, Environmental Impact Assessment Company AGC Environmental Offers Them Insights on Obtaining Expert Mold Remediation and Inspection
6. Nuanced Media: Custom Solar and Leisure to Showcase Products, Services at SAHBA Home & Patio Show
7. Report Says Mold Stirs Herndon High School, My Cleaning Products Asserts Organic-Based and No-Scrubbing Mold Remediation Products Are the Answers to the Mold Problem
8. HCCS Releases New Social Media Online Training Course
9. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
10. Verdad Media’s Unique MANIS Technology Means Better Reputation Management Results for Clients
11. SAFC Expands Irvine Facility to Add Dry Powder Media Manufacturing Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):